Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats
One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor ant...
Saved in:
Published in: | Psychopharmacologia Vol. 116; no. 2; pp. 237 - 241 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin
Springer
01-10-1994
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist (0.04-0.64 mg/kg orally), antagonizes (50-65%) yawning induced by apomorphine (0.07 mg/kg SC) or bromocriptine (2 mg/kg IP) in rats, and turning behaviour induced by intrastriatal injection of apomorphine (0.25 micrograms), (+) SKF 38393 (0.1 micrograms), bromocriptine (0.01 ng) or (+) amphetamine (10 micrograms) in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation. |
---|---|
AbstractList | One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonist have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist, antagonizes (50-65%) yawning induced by apomorphine or bromocriptine in rats, and turning behaviour induced by intrastriatal injection of apomorphine, (+) SKF 38393 bromocriptine or (+) amphetamine in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation. (DBO) One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct or indirect DA agonists have been reported to promote neurotensin release. We have found that SR 48692, a non-peptide neurotensin receptor antagonist (0.04-0.64 mg/kg orally), antagonizes (50-65%) yawning induced by apomorphine (0.07 mg/kg SC) or bromocriptine (2 mg/kg IP) in rats, and turning behaviour induced by intrastriatal injection of apomorphine (0.25 micrograms), (+) SKF 38393 (0.1 micrograms), bromocriptine (0.01 ng) or (+) amphetamine (10 micrograms) in mice. Other apomorphine-induced effects in mice and rats such as climbing, hypothermia, hypo- and hyper-locomotion, penile erections and stereotypies were not significantly modified by SR 48692. Taken together, these data suggest that neurotensin may play a permissive role in the expression of some but not all behavioural responses to DA receptor stimulation. |
Author | SOUILHAC, J PONCELET, M LE FUR, G GULLY, D SOUBRIE, P GUEUDET, C TERRANOVA, J. P |
Author_xml | – sequence: 1 givenname: M surname: PONCELET fullname: PONCELET, M organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 2 givenname: J surname: SOUILHAC fullname: SOUILHAC, J organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 3 givenname: C surname: GUEUDET fullname: GUEUDET, C organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 4 givenname: J. P surname: TERRANOVA fullname: TERRANOVA, J. P organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 5 givenname: D surname: GULLY fullname: GULLY, D organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 6 givenname: G surname: LE FUR fullname: LE FUR, G organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France – sequence: 7 givenname: P surname: SOUBRIE fullname: SOUBRIE, P organization: Sanofi Recherche, neuropsychiatry dep., 34184 Montpellier, France |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3315483$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/7862953$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9rFjEQxoNU6tvqxbuQg3go3Zq_m-yxllYLBaHqeckmE43sJmuSbfFL-Jkb6Us9OpcZnvnNM4fnCB3EFAGh15ScUULU-w9XhDEhSa-eoR0VnHWMKHaAdoRw3nEq9Qt0VMpP0kpocYgOle7ZIPkO_bn0HmwtOHn85RYL3Q_sFBtcYG5yuAPcfnUrrDW4NsOWU4VYQsQZbFNTxiZW8z3FUOopThHX-4RdWs0SInQOVogOYsUT_DB3IW3ZzO20rCkWKLj5LMFC83A4m1peoufezAVe7fsx-nZ1-fXiU3fz-eP1xflNZ5lUtQPvjQQ99JNhEgxjlNlecaAaiBwEcdYqOYEn1BCnNZm0dBQm2feDVoNn_Bi9e_Rdc_q1QanjEoqFeTYR0lZGpVQvqZD_BWmviZKCN_DkEbQ5lZLBj2sOi8m_R0rGvymN_1Jq8Ju96zYt4J7QfSxt_3a_N8Wa2WcTbShPGG-RCs35A3FJm-Q |
CODEN | PSYPAG |
CitedBy_id | crossref_primary_10_1006_frne_1996_0146 crossref_primary_10_1016_j_reprotox_2023_108498 crossref_primary_10_1016_0143_4179_95_90053_5 crossref_primary_10_1016_j_peptides_2003_06_004 crossref_primary_10_1016_S0006_8993_96_01380_7 crossref_primary_10_1016_j_schres_2011_10_013 crossref_primary_10_1016_S0165_6147_97_90666_0 crossref_primary_10_1111_j_1749_6632_1997_tb46151_x crossref_primary_10_1016_S0143_4179_96_90002_5 crossref_primary_10_1016_j_peptides_2006_04_024 crossref_primary_10_1111_j_1472_8206_1995_tb00528_x crossref_primary_10_1016_j_bbr_2014_11_014 crossref_primary_10_1016_j_neuropharm_2004_03_001 crossref_primary_10_1016_S0165_6147_97_01109_7 crossref_primary_10_1046_j_1471_4159_2001_00353_x crossref_primary_10_1002__SICI_1098_2396_199708_26_4_370__AID_SYN5_3_0_CO_2_3 |
Cites_doi | 10.1073/pnas.89.12.5591 10.1016/0163-7258(89)90046-6 10.1016/0006-8993(89)90627-6 10.1007/BF00178206 10.1016/0028-3908(93)90057-A 10.1016/0196-9781(91)90129-D 10.1016/0028-3908(89)90194-9 10.1016/0091-3057(91)90307-N 10.1016/0014-2999(89)90098-8 10.1016/0304-3940(92)90698-7 10.1016/0028-3908(85)90190-X 10.1016/0304-3940(90)90721-K 10.1007/BF00310640 10.1016/0304-3940(94)90851-6 10.1016/0024-3205(86)90397-8 10.1111/j.1476-5381.1992.tb09037.x 10.1016/0006-8993(91)90139-M 10.1073/pnas.90.1.65 10.1016/0165-0173(93)90008-N 10.1016/0014-2999(90)90361-9 10.1016/0014-2999(78)90134-6 10.1016/0028-3908(91)90038-D 10.1016/0091-3057(84)90229-6 |
ContentType | Journal Article |
Copyright | 1995 INIST-CNRS |
Copyright_xml | – notice: 1995 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7TK 7X8 |
DOI | 10.1007/BF02245067 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Animal Behavior Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Neurosciences Abstracts Animal Behavior Abstracts MEDLINE - Academic |
DatabaseTitleList | Neurosciences Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1432-2072 |
EndPage | 241 |
ExternalDocumentID | 10_1007_BF02245067 7862953 3315483 |
Genre | Journal Article |
GroupedDBID | -4W -BR .55 3SX 40D 40E 95. 95~ ABMNI AGWIL ALMA_UNASSIGNED_HOLDINGS IQODW KOW N2Q R9- RHV SBY SOJ X7M ~EX CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QG 7TK 7X8 |
ID | FETCH-LOGICAL-c257t-effa5e896ba25ea2212c673e18e05940dcc75bef01a0d880b85d1eb5669879f23 |
ISSN | 0033-3158 |
IngestDate | Fri Aug 16 07:34:02 EDT 2024 Fri Aug 16 08:46:06 EDT 2024 Fri Aug 23 02:16:33 EDT 2024 Sat Sep 28 08:38:20 EDT 2024 Tue Sep 20 22:55:05 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Vertebrata Mammalia Dopamine Rat Mouse Dopamine receptor Animal Neuromediator Rodentia Behavior Neurotensin Catecholamine |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c257t-effa5e896ba25ea2212c673e18e05940dcc75bef01a0d880b85d1eb5669879f23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
PMID | 7862953 |
PQID | 16807543 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_77765145 proquest_miscellaneous_16807543 crossref_primary_10_1007_BF02245067 pubmed_primary_7862953 pascalfrancis_primary_3315483 |
PublicationCentury | 1900 |
PublicationDate | 1994-10-00 |
PublicationDateYYYYMMDD | 1994-10-01 |
PublicationDate_xml | – month: 10 year: 1994 text: 1994-10-00 |
PublicationDecade | 1990 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany |
PublicationTitle | Psychopharmacologia |
PublicationTitleAlternate | Psychopharmacology (Berl) |
PublicationYear | 1994 |
Publisher | Springer |
Publisher_xml | – name: Springer |
References | CT Dourish (BF02245067_CR3) 1985; 24 CB Nemeroff (BF02245067_CR12) 1983; 225 NRF Al-Rhodan (BF02245067_CR1) 1991; 557 KM Merchant (BF02245067_CR10) 1990; 255 B Sanz (BF02245067_CR18) 1993; 4 FB Jolicoeur (BF02245067_CR7) 1991; 38 KM Merchant (BF02245067_CR9) 1989; 160 AJ Puech (BF02245067_CR16) 1978; 50 MJ During (BF02245067_CR4) 1992; 140 P Worms (BF02245067_CR26) 1986; 39 V Seutin (BF02245067_CR19) 1989; 28 M Poncelet (BF02245067_CR14) 1993; 32 JL Waddington (BF02245067_CR25) 1989; 43 AJ Bean (BF02245067_CR2) 1990; 108 K Fuxe (BF02245067_CR5) 1992; 89 NA Singh (BF02245067_CR20) 1990; 187 S Tanganelli (BF02245067_CR23) 1989; 502 MR Zarrindast (BF02245067_CR27) 1992; 105 M Morelli (BF02245067_CR11) 1986; 89 I Ushijima (BF02245067_CR24) 1984; 21 D Gully (BF02245067_CR6) 1993; 90 D Nouel (BF02245067_CR13) 1991; 12 P W Kalivas (BF02245067_CR8) 1993; 18 R Steinberg (BF02245067_CR21) 1994; 166 M Poncelet (BF02245067_CR15) 1994; 349 R Rivest (BF02245067_CR17) 1991; 30 AJ Stoessel (BF02245067_CR22) 1987; 93 |
References_xml | – volume: 89 start-page: 5591 year: 1992 ident: BF02245067_CR5 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.89.12.5591 contributor: fullname: K Fuxe – volume: 43 start-page: 1 year: 1989 ident: BF02245067_CR25 publication-title: Pharmacol Ther doi: 10.1016/0163-7258(89)90046-6 contributor: fullname: JL Waddington – volume: 502 start-page: 319 year: 1989 ident: BF02245067_CR23 publication-title: Brain Res doi: 10.1016/0006-8993(89)90627-6 contributor: fullname: S Tanganelli – volume: 349 start-page: 57 year: 1994 ident: BF02245067_CR15 publication-title: Naunyn-Schmiedeberg's Arch Pharmacol doi: 10.1007/BF00178206 contributor: fullname: M Poncelet – volume: 4 start-page: 1194 year: 1993 ident: BF02245067_CR18 publication-title: NeuroReport contributor: fullname: B Sanz – volume: 32 start-page: 605 year: 1993 ident: BF02245067_CR14 publication-title: Neuropharmacology doi: 10.1016/0028-3908(93)90057-A contributor: fullname: M Poncelet – volume: 12 start-page: 755 year: 1991 ident: BF02245067_CR13 publication-title: Peptides doi: 10.1016/0196-9781(91)90129-D contributor: fullname: D Nouel – volume: 28 start-page: 949 year: 1989 ident: BF02245067_CR19 publication-title: Neuropharmacology doi: 10.1016/0028-3908(89)90194-9 contributor: fullname: V Seutin – volume: 38 start-page: 463 year: 1991 ident: BF02245067_CR7 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(91)90307-N contributor: fullname: FB Jolicoeur – volume: 160 start-page: 409 year: 1989 ident: BF02245067_CR9 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(89)90098-8 contributor: fullname: KM Merchant – volume: 140 start-page: 129 year: 1992 ident: BF02245067_CR4 publication-title: Neurosci Lett doi: 10.1016/0304-3940(92)90698-7 contributor: fullname: MJ During – volume: 24 start-page: 1051 year: 1985 ident: BF02245067_CR3 publication-title: Neuropharmacology doi: 10.1016/0028-3908(85)90190-X contributor: fullname: CT Dourish – volume: 108 start-page: 143 year: 1990 ident: BF02245067_CR2 publication-title: Neurosci Lett doi: 10.1016/0304-3940(90)90721-K contributor: fullname: AJ Bean – volume: 93 start-page: 336 year: 1987 ident: BF02245067_CR22 publication-title: Psychopharmacology contributor: fullname: AJ Stoessel – volume: 89 start-page: 259 year: 1986 ident: BF02245067_CR11 publication-title: Psychopharmacology doi: 10.1007/BF00310640 contributor: fullname: M Morelli – volume: 166 start-page: 106 year: 1994 ident: BF02245067_CR21 publication-title: Neurosci Letter doi: 10.1016/0304-3940(94)90851-6 contributor: fullname: R Steinberg – volume: 225 start-page: 337 year: 1983 ident: BF02245067_CR12 publication-title: J Pharmacol Exp Ther contributor: fullname: CB Nemeroff – volume: 39 start-page: 2199 year: 1986 ident: BF02245067_CR26 publication-title: Life Sci doi: 10.1016/0024-3205(86)90397-8 contributor: fullname: P Worms – volume: 105 start-page: 675 year: 1992 ident: BF02245067_CR27 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.1992.tb09037.x contributor: fullname: MR Zarrindast – volume: 557 start-page: 227 year: 1991 ident: BF02245067_CR1 publication-title: Brain Res doi: 10.1016/0006-8993(91)90139-M contributor: fullname: NRF Al-Rhodan – volume: 90 start-page: 65 year: 1993 ident: BF02245067_CR6 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.90.1.65 contributor: fullname: D Gully – volume: 18 start-page: 75 year: 1993 ident: BF02245067_CR8 publication-title: Brain Res Rev doi: 10.1016/0165-0173(93)90008-N contributor: fullname: P W Kalivas – volume: 255 start-page: 775 year: 1990 ident: BF02245067_CR10 publication-title: J Pharmacol Exp Ther contributor: fullname: KM Merchant – volume: 187 start-page: 337 year: 1990 ident: BF02245067_CR20 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(90)90361-9 contributor: fullname: NA Singh – volume: 50 start-page: 291 year: 1978 ident: BF02245067_CR16 publication-title: Eur J Pharmacol doi: 10.1016/0014-2999(78)90134-6 contributor: fullname: AJ Puech – volume: 30 start-page: 25 year: 1991 ident: BF02245067_CR17 publication-title: Neuropharmacology doi: 10.1016/0028-3908(91)90038-D contributor: fullname: R Rivest – volume: 21 start-page: 297 year: 1984 ident: BF02245067_CR24 publication-title: Pharmacol Biochem Behav doi: 10.1016/0091-3057(84)90229-6 contributor: fullname: I Ushijima |
SSID | ssj0000484 ssj0068394 |
Score | 1.5943074 |
Snippet | One major mechanism underlying the central action of neurotensin is an interaction with the function of dopamine (DA)-containing neurons. In addition, direct... |
SourceID | proquest crossref pubmed pascalfrancis |
SourceType | Aggregation Database Index Database |
StartPage | 237 |
SubjectTerms | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - antagonists & inhibitors 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine - pharmacology Animals Apomorphine - antagonists & inhibitors Apomorphine - pharmacology Behavior, Animal - drug effects Behavioral psychophysiology Biological and medical sciences Bromocriptine - antagonists & inhibitors Bromocriptine - pharmacology Dopamine - physiology Dose-Response Relationship, Drug Female Fundamental and applied biological sciences. Psychology Male Mice Motor Activity - drug effects Neurotransmission and behavior Penile Erection - drug effects Psychology. Psychoanalysis. Psychiatry Psychology. Psychophysiology Pyrazoles - pharmacology Quinolines - pharmacology Rats Rats, Wistar Receptors, Neurotensin - antagonists & inhibitors Stereotyped Behavior - drug effects Yawning - drug effects |
Title | Effects of SR 48692, a selective non-peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7862953 https://search.proquest.com/docview/16807543 https://search.proquest.com/docview/77765145 |
Volume | 116 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpC2MwxtatLNu6CTb6khhs-SL5sWzuwsi60LjQNyNLMht0cUjilv2J_eYdWbKVUHZ72ItxhCMnnM_nYn3nE0JvBYS5JC0FFDll6kG8Vh6HwO0RUVEWiJCHrbr-ZE7Pr9j7LMoGg44s7Mb-q6VhDGytO2f_wdr9pDAA52BzOILV4fhXds8cQWN-MYpYkpKWoTlatzveaKIQVPzeUrNZJJxrcY6Wxa77WjTHpWVV6rUqramrv6qXE27rkYTy-hvkpF63b-6m6_FvlTtWhmzb8rtGeo97w1znRimqy3-Nv106vez-jf5M909em6URt8dx3Xy9_sLFzvrVh0Y10lzoXpKrFQTd-sYwf23TmrTdfVFPi-sddKjb_Yyae--gTTemRSLZdrdGMMZGbmIktO4EBb-jukO6EvsJdaGvW-4__1ycXU6nRZ5d5XvogIDTAp95cJp9nExdXI90S6_5kEBeaQS-7e_dVb61N9rJdR4s-Roeu8rsl_LrgqZNbPJH6KGtSPCpgdJjNFCLQ3Tvk-VcHKKTmbHW9zHOXbPeeoxP8GzLjk_QDws9XFd4foFb6I0xxz3w8Bbw8BbwcAc87IA3xvUCA-zwXdjhLdjhHnYY5tGwgzkk1rB7ii7PsvzdxLPbfXgC4sbGU1XFY8XSpOQkVpxAUiUSGqqAKS0q5EshaFyqyg-4LyHslCyWgSqhHkkZTSsSHqF9-B_qmRYioDIIREB4UEZExjwKmEgheCWM8YrKIXrTGaZYGlWXotPvduYbouMdm_WXhqEu9MMhet3ZsACnrFfa-ELVzboIEq3xHf3mCkppArVKPERHxvj95JQlJI3D53-c_AW67x6hl2h_s2rUMdpby-aVhe5PlqC_3A |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+SR+48692%2C+a+selective+non-peptide+neurotensin+receptor+antagonist%2C+on+two+dopamine-dependent+behavioural+responses+in+mice+and+rats&rft.jtitle=Psychopharmacology&rft.au=Poncelet%2C+M&rft.au=Souilhac%2C+J&rft.au=Gueudet%2C+C&rft.au=Terranova%2C+J+P&rft.date=1994-10-01&rft.issn=0033-3158&rft.volume=116&rft.issue=2&rft.spage=237&rft.epage=241&rft_id=info:doi/10.1007%2FBF02245067&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-3158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-3158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-3158&client=summon |